NCATS announces strategic plan for 2025–2030

Under NCATS' leadership, the Clinical and Translational Science Awards (CTSA) Program funds NC TraCS as part of a national network of medical institutions that speed the translation of research discoveries into improved care.

NCATS has recently announced its new strategic plan for 2025-2030 as a tool to help guide its mission of turning research observations into health solutions through translational science.

In a Director's Message from Joni Rutter, she notes:

"Over the last 10 years, our Clinical and Translational Science Awards (CTSA) Program and Rare Diseases Clinical Research Network (RDCRN) have shown the power of engaging patients and communities throughout the entire research process. This approach led to innovations and interventions that are now saving lives and improving health. These initiatives — and many others — will play a big role under our new strategic directions."

View the Director's Message and new strategic plan at ncats.nih.gov.